Market Closed

ZBIO
Zenas BioPharma
$ 28.01
1.34%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Zenas BioPharma News

Latest Zenas BioPharma Stock News & ZBIO Headlines

Zenas BioPharma, Inc. $ZBIO Shares Acquired by Alps Advisors Inc.
4 days ago | defenseworld.net
Zenas BioPharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
10 days ago | globenewswire.com
Zenas BioPharma Eyes Key Lupus and IL-17 Data as Obexelimab FDA Decision Nears
16 days ago | marketbeat.com
Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development Transcript
19 days ago | seekingalpha.com
Wall Street Analysts Predict a 77.61% Upside in Zenas BioPharma, Inc. (ZBIO): Here's What You Should Know
23 days ago | zacks.com
Zenas BioPharma to Host Virtual R&D Event
a month ago | globenewswire.com
Zenas BioPharma: Obexelimab Is Being Graded On The Wrong Curve
a month ago | seekingalpha.com
Zenas BioPharma, Inc. (ZBIO) Discusses Obexelimab Prelaunch Strategy and Commercial Opportunity in IgG4-Related Disease Transcript
2 months ago | seekingalpha.com
Zenas BioPharma, Inc. (ZBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago | seekingalpha.com
Zenas BioPharma, Inc. (ZBIO) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
2 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ZBIO
Zenas BioPharma
$ 28.01
1.34%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago